Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shilpa Medicare has informed that Dr. Uday N. Harle has been appointed as the Chief Executive Officer (CEO) - Shilpa Biologicals, a Wholly Owned Subsidiary of the company (Senior Managerial Personnel) of the Company with effect from 03 August 2026. The requisite details as prescribed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated 30th January 2026, are enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
